• No results found

1 to 3.5 V

Complete V.5 Number 1

Complete V.5 Number 1

... 35. See Billings, Preface and Introduction in A N U NCOMMON E XPERIENCE , supra note 3, at 6, 16-17, and Fernandez, Louisiana Legal History, supra note 4, at 9-12. Kilbourne’s rejection of the clash thesis, at ...

354

Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins (αVβ5, αVβ3, and α3β1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection

Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins (αVβ5, αVβ3, and α3β1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection

... ␣ V3 and CD98 was ob- served as early as 1 min ...␤ 3 integrin ...␣ V5 and ␣ V3 integrins in KSHV-infected ...␣ V5 integrin antibody (top) ...

19

5 Cyclo­hexyl 2 methyl 3 (3 methyl­phenyl­sulfon­yl) 1 benzo­furan

5 Cyclo­hexyl 2 methyl 3 (3 methyl­phenyl­sulfon­yl) 1 benzo­furan

... of 5-cyclo- hexyl-2-methyl-3-(3-methylphenylsulfanyl)-1-benzofuran (302 mg, ...4:1 v/v) to afford the title compound as a colorless solid [yield 73%, ...

9

5 Fluoro 2 methyl 3 (3 methyl­phenyl­sulfon­yl) 1 benzo­furan

5 Fluoro 2 methyl 3 (3 methyl­phenyl­sulfon­yl) 1 benzo­furan

... of 5-fluoro-2- methyl-3-(3-methylphenylsulfanyl)-1-benzofuran (245 mg, ...4:1 v/v) to afford the title compound as a colorless solid [yield 71%, ...

8

5 Cyclo­hexyl 3 ethyl­sulfinyl 2 (3 fluoro­phen­yl) 1 benzo­furan

5 Cyclo­hexyl 3 ethyl­sulfinyl 2 (3 fluoro­phen­yl) 1 benzo­furan

... of 5-cyclo- hexyl-3-ethylsulfanyl-2-(3-fluorophenyl)-1-benzofuran (283 mg, ...2:1 v/v) to afford the title compound as a colourless solid [yield 70%, ...

8

5 Chloro 3 ethyl­sulfinyl 2 (3 fluoro­phen­yl) 1 benzo­furan

5 Chloro 3 ethyl­sulfinyl 2 (3 fluoro­phen­yl) 1 benzo­furan

... of 5-chloro-3- ethylsulfanyl-2-(3-fluorophenyl)-1-benzofuran (337 mg, ...2:1 v/v) to afford the title compound as a colorless solid [yield 67%, ...

10

5 Bromo 2,4,6 tri­methyl 3 (3 methyl­phenyl­sulfin­yl) 1 benzo­furan

5 Bromo 2,4,6 tri­methyl 3 (3 methyl­phenyl­sulfin­yl) 1 benzo­furan

... bromo-2,4,6-trimethyl-3-(3-methylphenylsulfanyl)-1-benzofuran (397 mg, 1.1 mmol) in dichloromethane (35 mL) at 273 K. After being stirred at room temperature for 5h, the mixture was washed with ...

8

3 Ethyl­sulfinyl 2 (3 fluoro­phen­yl) 5 phenyl 1 benzo­furan

3 Ethyl­sulfinyl 2 (3 fluoro­phen­yl) 5 phenyl 1 benzo­furan

... of 3-ethyl- sulfanyl-2-(3-fluorophenyl)-5-phenyl-1-benzofuran (278 mg, ...2:1 v/v) to afford the title compound as a colorless solid [yield 62%, ...

9

5 Cyclo­hexyl 3 (3 fluoro­phenyl­sulfon­yl) 2 methyl 1 benzo­furan

5 Cyclo­hexyl 3 (3 fluoro­phenyl­sulfon­yl) 2 methyl 1 benzo­furan

... 77% 3-chloroperoxybenzoic acid (515 mg, ...of 5-cyclo- hexyl-3-(3-fluorophenylsulfanyl)-2-methyl-1-benzofuran (374 mg, ...4:1 v/v) to afford the title compound as a ...

9

5 Bromo 2,7 di­methyl 3 (3 methyl­phenyl­sulfon­yl) 1 benzo­furan

5 Bromo 2,7 di­methyl 3 (3 methyl­phenyl­sulfon­yl) 1 benzo­furan

... of 5-bromo-2,7- dimethyl-3-(3-methylphenylsulfanyl)-1-benzofuran (312 mg, ...4:1 v/v) to afford the title compound as a colorless solid [yield 68%, ...

8

5 Cyclo­hexyl 2 methyl 3 (3 methyl­phenyl­sulfin­yl) 1 benzo­furan

5 Cyclo­hexyl 2 methyl 3 (3 methyl­phenyl­sulfin­yl) 1 benzo­furan

... of 5-cyclo- hexyl-2-methyl-3-(3-methylphenylsulfanyl)-1-benzofuran (302 mg, ...2:1 v/v) to afford the title compound as a colorless solid [yield 75%, ...

9

5 Ethyl 3 (3 fluoro­phenyl­sulfon­yl) 2 methyl 1 benzo­furan

5 Ethyl 3 (3 fluoro­phenyl­sulfon­yl) 2 methyl 1 benzo­furan

... 77% 3-Chloroperoxybenzoic acid (560 mg, ...of 5-ethyl-3-(3- fluorophenylsulfanyl)-2-methyl-1-benzofuran (320 mg, ...4:1 v/v) to afford the title compound as a ...

9

Industrial Democracy: a Study of Labor Payment, Conditions, and Tendencies

Industrial Democracy: a Study of Labor Payment, Conditions, and Tendencies

... ~ , ,, '!' , T~ ~ !p1 T ? 't i ?; I ; L 1 l ? ~~~ ,, , , , r ("f ~v? ~ ~ v ~ 1\3 f1"' , ,'i '"t ,, , 7 ""'i ~ ' ' 5 3 ~ , , ,, , oo 77 , I Sines the beginn i ng of human relatio!ls ~ some of the more[.] ...

80

5 (p Tolylsulfon­yl) 3 oxa 5 aza­tri­cyclo­[5 2 1 04,8]deca­ne

5 (p Tolylsulfon­yl) 3 oxa 5 aza­tri­cyclo­[5 2 1 04,8]deca­ne

... crude product was purified by flash column chromatography (silica gel; hexane–EtOAc 1:5 v/v) to give 55.6 mg (58%) of the title compound, which was recrystallized from EtOH for X-ray analysis. ...

7

5 Bromo 2 methyl 3 (3 methyl­phenyl­sulfin­yl) 1 benzo­furan

5 Bromo 2 methyl 3 (3 methyl­phenyl­sulfin­yl) 1 benzo­furan

... of 5-bromo-2- methyl-3-(3-methylphenylsulfanyl)-1-benzofuran (300 mg, ...2:1 v/v) to afford the title compound as a colorless solid [Yield 78%, ...

8

Early Events in Kaposi's Sarcoma-Associated Herpesvirus Infection of Target Cells

Early Events in Kaposi's Sarcoma-Associated Herpesvirus Infection of Target Cells

... ␣ V3 and ␣ V5 antibodies and peptide-bound beads, de- tected only ␣ V3 integrin ...␣ V3 antibodies, anti- ␣ 31 and - ␣ V ␤ ...

12

A Kaposi's Sarcoma-Associated Herpesvirus Infection Mechanism Is Independent of Integrins α3β1, αVβ3, and αVβ5

A Kaposi's Sarcoma-Associated Herpesvirus Infection Mechanism Is Independent of Integrins α3β1, αVβ3, and αVβ5

... ␣ 31, ␣ V3, and ␣ V5; erythropoietin-producing hepatocellular (Eph) recep- tor A2 (EphA2); and SLC7A11/xCT to trigger clathrin-mediated endocytosis or macropi- nocytosis ...

22

Integrin αvβ1 Is a Receptor for Foot-and-Mouth Disease Virus

Integrin αvβ1 Is a Receptor for Foot-and-Mouth Disease Virus

... Several viruses have been reported to utilize multiple RGD- dependent integrins to initiate infection (see the introduction). Prior to these studies, FMDV was reported to use two ␣v integrins, ␣v3 ...

7

5 (1 Acet­amido 3 methyl­butyl) 5 methyl­imidazolidine 2,4 dione monohydrate

5 (1 Acet­amido 3 methyl­butyl) 5 methyl­imidazolidine 2,4 dione monohydrate

... Hydantoins, well known for their central nervous system activity (Tunnicliff, 1996; Morkunas & Miller, 1997), have been reported to possess a variety of pharmacological properties. 5,5±Disubstituted hydantoins often ...

9

5′′ Benzyl­­idene 5 chloro 1′,1′′ di­methyl 4′ phenyl­di­spiro­[indoline 3,2′ pyrrolidine 3′,3′′ piperidine] 2,4′′ dione

5′′ Benzyl­­idene 5 chloro 1′,1′′ di­methyl 4′ phenyl­di­spiro­[indoline 3,2′ pyrrolidine 3′,3′′ piperidine] 2,4′′ dione

... A mixture of equimolar amounts of 3E,5E-1-methyl-3,5-bis(phenylmethylidene)-4-piperidone (5 mmol), prepared by a literature procedure (Al-Omary et al., 2012), 5-chloroisatin and sarcosine in absolute ...

12

Show all 10000 documents...

Related subjects